{"brief_title": "Evaluation of Liquid vs. Tablet Buprenorphine - 6", "brief_summary": "The purpose of this study is to evaluate the steady-state pharmacokinetics and bioavailability of buprenorphine sublingual tablets vs. sublingual solution.", "condition": ["Opioid-Related Disorders"], "intervention_type": ["Drug"], "intervention_name": ["Buprenorphine"], "criteria": "Inclusion Criteria: M/F ages 21-50. Meet DSM-IV criteria for opioid dependence. Agree to conditions of the study and sign informed consent. Exclusion Criteria: Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical condtions that deem participation to be unsafe.", "gender": "All", "minimum_age": "21 Years", "maximum_age": "50 Years", "healthy_volunteers": "No", "keyword": "opioid dependence", "mesh_term": ["Opioid-Related Disorders", "Buprenorphine"], "id": "NCT00000341"}